Prieels Pharma SRL
Prieels Pharma reported total assets of €1.29m at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Aug 2026).
The score of Prieels Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1023 % Total assets +4528 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Prieels Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Aug 2026
- Year ended 31 Dec 2024filed on 07 Aug 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 18 Aug 2023
Prieels Pharma's financial analysis
- Solvency8.9%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Prieels Pharma
Prieels Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0787.996.326
- VAT number
- BE0787996326
- Peppol
- Registered · 0208:0787996326 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Jul 2022
- Registered office
- 3050 Oud-Heverlee
- Latest accounts
- 2025 · filed on 24 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Prieels Pharma (SRL) has been based in Oud-Heverlee since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 73,832 € and equity of 114,791 €; its revenue is not published. Its solvency stands at 8.9%, below the median of its sector (44.0%).
Companies similar to Prieels Pharma
Companies in the same business, of comparable size and area, outside its group.
- Crobephar Business and other management consultancy activities Quévy · balance sheet €1.56m
- Mathis Pharma Business and other management consultancy activities Bruges · balance sheet €1.06m
- T-Oline Business and other management consultancy activities Ferrières · balance sheet 987,312 €
- VVD SRL Retail sale of pharmaceutical products Ixelles · balance sheet 956,770 €
- Juclé Retail sale of pharmaceutical products Sint-Truiden · balance sheet €1.06m
- Bayart Hensies Retail sale of pharmaceutical products Dour · balance sheet €1.14m
- VAN Rengen - Versele Retail sale of pharmaceutical products Horebeke · balance sheet €1.92m
- Antares Invest Retail sale of pharmaceutical products Celles (lez-Tournai) · balance sheet €1.80m
Frequently asked questions about Prieels Pharma
What is the revenue of Prieels Pharma?
Prieels Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Prieels Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0787996326 for Prieels Pharma, if the company is VAT-registered. Its company number (CBE) is 0787.996.326.
Where is the registered office of Prieels Pharma?
According to the CBE register, the registered office of Prieels Pharma is in 3050 Oud-Heverlee.
What is the equity of Prieels Pharma?
At the close of the 2025 financial year, the equity of Prieels Pharma amounts to 114,791 €, a solvency of 8.9% of total assets.
Who manages Prieels Pharma?
The register lists 1 active mandates at Prieels Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Prieels Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →